Camilo Quevedo

MSc, PhD

Business Manager

Professional Services role

I am a business manager at the University of Oxford, supporting the Centre for Immuno-Oncology. As the BM of the centre, I provide operational, financial and strategic support to the Centre. During my career in administration, I have also provided management support to other NDM units such as The Centre for Human Genetics and The Jenner Institute.

Background

I have a scientific background, with a PhD in Medicinal Chemistry from the Institute of Cancer Research, and several years of experience at the University of Oxford as a post-doctoral researcher and as Project Leader in drug discovery projects against relevant cancer targets.

Recent publications

Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compounds.

Cruz-Migoni A. et al, (2019), Proceedings of the National Academy of Sciences of the United States of America, 116, 2545 - 2550

Abstract

(2018)

Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment.

Quevedo CE. et al, (2018), Nature communications, 9

Correction: BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions.

Bery N. et al, (2018), eLife, 7

BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions.